This bill requires health insurance plans covering groups of 50+ people in New Jersey to cover standard fertility preservation services (like egg or embryo freezing) for individuals diagnosed with specific menstrual disorders - such as endometriosis, heavy bleeding, or uterine fibroids - that may cause infertility. It mandates coverage when a medically necessary treatment could cause infertility or for those with qualifying disorders, applying the same copays, deductibles, and benefit limits as other medical conditions. Insurers cannot deny coverage based on age, sex, sexual orientation, or other personal characteristics. The law amends existing insurance regulations to ensure equitable access to these services for affected individuals.
This bill requires all health insurance plans in New Jersey to cover pelvic floor physical therapy for one year after childbirth. It applies to hospital service, medical service, health service, individual, group, and health benefits plans. The coverage must be provided at the same level as for other medical conditions, meaning no higher out-of-pocket costs or restrictions than standard medical care. This directly affects women who have given birth and are covered by these insurance plans during the postpartum period.
This bill requires all health insurers operating in New Jersey - including hospital service corporations, medical service corporations, health service corporations, individual health insurance policies, group health plans, and individual health benefits plans - to cover the diagnosis, evaluation, and treatment of lymphedema when deemed medically necessary by a patient’s physician. It applies to all such insurance contracts delivered, issued, or renewed in New Jersey after the bill’s effective date, mandating coverage at the same level and cost-sharing (like deductibles and coinsurance) as for other similar medical services. The bill directly affects patients with lymphedema and insurers by ensuring this specific condition is treated as a standard covered service under existing policies. It does not alter overall coverage limits or introduce new funding, but expands mandatory benefits to include lymphedema care.
This bill prohibits pharmacy benefits managers (PBMs) from requiring individuals covered by health insurance plans to use mail-order pharmacies or automatically enrolling them in such programs without consent. It directly affects people covered under private health insurers, prescription benefit plans, or New Jersey's State Health Benefits Program and School Employees' Health Benefits Program. The key provision requires PBMs to offer a choice between mail and non-mail pharmacies, with written consent required before using a mail service option. The law takes effect January 1, 2027, ensuring covered persons can select their preferred pharmacy type without forced enrollment.
This bill (A 503) allows New Jersey residents to purchase health insurance policies sold by insurers licensed in other states ("foreign health insurers"). It directly affects New Jersey residents (defined as those living in the state for at least six months annually) and their employers, who may reimburse employees for these out-of-state policies. Key provisions require that such purchases satisfy any legal requirement for health insurance coverage, and employers may cover the costs of these policies. The bill takes effect 90 days after enactment, expanding insurance purchasing options beyond New Jersey’s regulated market.
This bill requires health insurers, the State Health Benefits Program (SHBP), and the State Employees Health Benefits Program (SEHBP) to cover specific mammogram screenings. It mandates one baseline mammogram for women aged 35 and annual screenings for women 35 and older, while also requiring coverage for women under 35 with breast cancer risk factors (like family history) as determined by their provider. Additional tests like ultrasounds or MRIs are covered if needed due to dense breast tissue, abnormal results, or other risk factors. The law applies to all health insurance plans in New Jersey, ensuring these screenings are covered without additional out-of-pocket costs for eligible individuals.
New Jersey bill A3128 requires all health insurance plans sold in the state to cover diagnostic and supplemental breast examinations with no out-of-pocket costs to patients. It applies to group and individual health insurance contracts, mandating that insurers pay for these exams without deductibles, copays, or coinsurance. Diagnostic exams evaluate abnormalities found during screenings or detected another way, while supplemental exams screen high-risk patients (e.g., those with dense breasts or family history) when no abnormality is present. The law aligns with National Comprehensive Cancer Network Guidelines and applies to all plans except those specifically structured as medical savings accounts under federal law. This directly affects all New Jersey residents with health insurance who may need these breast exams.
This bill requires all health insurance plans in New Jersey to cover specific prenatal genetic tests during the first trimester of pregnancy. It applies to hospital service, medical service, health service, individual, and group insurance policies issued in the state. Covered tests include carrier screening (a blood or cheek swab test for inherited disorders), nuchal translucency screening, and chorionic villus sampling. Insurance plans must provide this coverage at the same level as other medical conditions, meaning no additional out-of-pocket costs for patients beyond standard coverage.
This bill requires all health insurance plans in New Jersey (including individual, group, and small employer plans) to cover comprehensive neuropsychological testing for suspected dyslexia. It mandates that insurers cannot exclude this coverage, ensuring testing for diagnosis and related psychological/emotional assessments is provided at the same level as other medical conditions. The law applies to all covered health insurance contracts issued or renewed in New Jersey after its effective date, directly affecting patients seeking dyslexia evaluations and insurers offering these plans. It does not create new funding but requires existing insurance policies to include this specific service. The bill is currently pending before the Assembly Financial Institutions and Insurance Committee.
This New Jersey bill (A-2201) requires health insurance companies to cover remote patient monitoring devices - like those tracking vital signs - from patients' homes on the same terms as in-person medical visits. It mandates that insurers pay the same reimbursement rate for remote monitoring as they would for in-person care and cannot charge higher deductibles, copays, or coinsurance for these services. The law also prohibits insurers from restricting how providers use technology (e.g., audio-only calls) or limiting coverage for routine remote check-ins, as long as care standards match in-person services. This directly affects health insurers, patients using remote monitoring, and healthcare providers delivering these services in New Jersey.